JP2017525702A - ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物 - Google Patents

ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物 Download PDF

Info

Publication number
JP2017525702A
JP2017525702A JP2017509000A JP2017509000A JP2017525702A JP 2017525702 A JP2017525702 A JP 2017525702A JP 2017509000 A JP2017509000 A JP 2017509000A JP 2017509000 A JP2017509000 A JP 2017509000A JP 2017525702 A JP2017525702 A JP 2017525702A
Authority
JP
Japan
Prior art keywords
pgrg1
composition
composition according
isolated
astragalus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017509000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525702A5 (enExample
Inventor
ジョン エイチ． ムッサー，
ジョン エイチ． ムッサー，
ジェンファ アン，
ジェンファ アン，
Original Assignee
ファーマジェネシス， インコーポレイテッド
ファーマジェネシス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーマジェネシス， インコーポレイテッド, ファーマジェネシス， インコーポレイテッド filed Critical ファーマジェネシス， インコーポレイテッド
Publication of JP2017525702A publication Critical patent/JP2017525702A/ja
Publication of JP2017525702A5 publication Critical patent/JP2017525702A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • C08B37/0048—Processes of extraction from organic materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017509000A 2014-08-18 2015-08-17 ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物 Pending JP2017525702A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462038583P 2014-08-18 2014-08-18
US62/038,583 2014-08-18
PCT/US2015/045574 WO2016028714A1 (en) 2014-08-18 2015-08-17 Polygalacturonan rhamnogalacturonan1 (pgrg1) composition

Publications (2)

Publication Number Publication Date
JP2017525702A true JP2017525702A (ja) 2017-09-07
JP2017525702A5 JP2017525702A5 (enExample) 2018-08-02

Family

ID=55351173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017509000A Pending JP2017525702A (ja) 2014-08-18 2015-08-17 ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物

Country Status (5)

Country Link
US (1) US20170232035A1 (enExample)
EP (1) EP3191110A4 (enExample)
JP (1) JP2017525702A (enExample)
CN (1) CN106794211A (enExample)
WO (1) WO2016028714A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105866318A (zh) * 2016-03-16 2016-08-17 保定冀中药业有限公司 一种麻杏石甘口服液中麻黄的薄层色谱检测方法
CN108084290A (zh) * 2018-01-09 2018-05-29 东北农业大学 一种微波辅助提取薇菜中多糖的方法
CN110128562B (zh) * 2019-05-29 2021-05-25 黄河科技学院 一种抗肿瘤补骨脂多糖及其提取分离方法和在制备抗肿瘤药物方面的应用
CN111999425A (zh) * 2020-08-21 2020-11-27 广东容大生物股份有限公司 一种银黄甘颗粒中甘草成分的定性鉴别方法
CN112961258B (zh) * 2021-02-26 2023-02-07 重庆医科大学附属第二医院 一种红参均一性多糖及其提取方法与应用
CN115078581B (zh) * 2022-06-21 2024-08-27 上海长征医院 基于uhplc-q-tof/ms识别柴胡桂枝干姜免煎剂成分的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502703A (ja) * 2000-06-29 2004-01-29 ファーマジェネシス，　インコーポレイテッド 酸修飾アラビノガラクタンタンパク質組成物
JP2004107295A (ja) * 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization ヒスタミン遊離抑制剤
JP2012512176A (ja) * 2008-12-15 2012-05-31 エコファーム、エルエルシー キバナオウギ抽出物を含む組成物による特発性血小板減少性紫斑病の治療
JP2013203739A (ja) * 2012-03-28 2013-10-07 Tcm Biotech Internatl Corp 肝線維化又は非アルコール性脂肪性肝を予防、治療する医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6203600A (en) * 1999-06-30 2001-01-31 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
CA2582428A1 (en) * 2004-03-26 2005-10-13 Glycogenesys, Inc. Modified pectins, compositions and methods related thereto
CN102762597A (zh) * 2009-12-11 2012-10-31 联合利华公众股份有限公司 适合调节免疫应答的多糖
ES2689261T3 (es) * 2011-04-29 2018-11-12 Nutrileads B.V. Método para el aislamiento de polisacáridos
JP6185473B2 (ja) * 2011-09-16 2017-08-23 ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 非アルコール性脂肪性肝炎および非アルコール性脂肪肝疾患を処置するためのガラクト−ラムノガラクツロネート組成物
ES2848538T3 (es) * 2012-06-06 2021-08-10 Galectin Therapeutics Inc Composiciones de galacto-ramnogalacturonato para el tratamiento de enfermedades asociadas con elevada óxido nítrico sintasa inducible

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502703A (ja) * 2000-06-29 2004-01-29 ファーマジェネシス，　インコーポレイテッド 酸修飾アラビノガラクタンタンパク質組成物
JP2004107295A (ja) * 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization ヒスタミン遊離抑制剤
JP2012512176A (ja) * 2008-12-15 2012-05-31 エコファーム、エルエルシー キバナオウギ抽出物を含む組成物による特発性血小板減少性紫斑病の治療
JP2013203739A (ja) * 2012-03-28 2013-10-07 Tcm Biotech Internatl Corp 肝線維化又は非アルコール性脂肪性肝を予防、治療する医薬組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXP. CLIN. ENDOCRINOL. DIABETES, vol. 114 (10), JPN6019005169, 2006, pages 563 - 568, ISSN: 0003978801 *
ZHONGGUO ZHONG, vol. 24 (19), JPN6019005171, 1999, pages 621 - 639, ISSN: 0004115636 *

Also Published As

Publication number Publication date
EP3191110A1 (en) 2017-07-19
CN106794211A (zh) 2017-05-31
EP3191110A4 (en) 2018-04-18
WO2016028714A1 (en) 2016-02-25
US20170232035A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
Meng et al. Extraction, characterization and anti-inflammatory activities of an inulin-type fructan from Codonopsis pilosula
JP2017525702A (ja) ポリガラクツロナンラムノガラクツロナン（ｐｇｒｇ１）組成物
Xie et al. Polysaccharide from alfalfa activates RAW 264.7 macrophages through MAPK and NF-κB signaling pathways
Li et al. Advances in the extraction, purification, structural characteristics and biological activities of Eleutherococcus senticosus polysaccharides: a promising medicinal and edible resource with development value
Wang et al. Effects of Lycium barbarum polysaccharides on immunity and the gut microbiota in cyclophosphamide-induced immunosuppressed mice
Niu et al. Effects of polysaccharide from Malus halliana Koehne flowers in cyclophosphamide‐induced immunosuppression and oxidative stress on mice
CN1842341B (zh) 从人参叶和茎分离的抗癌以及抗转移活性级分
Cui et al. Beneficial effects of sulfated polysaccharides from the red seaweed Gelidium pacificum Okamura on mice with antibiotic-associated diarrhea
Zhou et al. Antitumor effects of polysaccharides from Tetrastigma hemsleyanum Diels et Gilg via regulation of intestinal flora and enhancing immunomodulatory effects in vivo
Liu et al. Structural properties and anti-inflammatory activity of purified polysaccharides from Hen-of-the-woods mushrooms (Grifola frondosa)
CN107714805B (zh) 衢枳壳提取物在制备中药制剂或功能性食品中的应用
Zhao et al. Promising natural products against SARS‐CoV‐2: Structure, function, and clinical trials
Zhang et al. Extraction, purification, structural characterization, bioactivities, modifications and structure–activity relationship of polysaccharides from Ophiopogon japonicus: A review
Park et al. High-molecular-weight Fucoidan exerts an immune-enhancing effect in RAW 264.7 cells and cyclophosphamide-induced immunosuppression rat by altering the gut microbiome
Liz et al. The anti‐inflammatory modulatory role of Solidago chilensis Meyen in the murine model of the air pouch
Choi et al. Korean ginseng berry polysaccharide enhances immunomodulation activities of peritoneal macrophages in mice with cyclophosphamide-induced immunosuppression
US20050287230A1 (en) Method of producing ginsenoside 20 (R)-Rh2 and composition of matter thereof
US5096708A (en) Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
Chen et al. Structural Characterization and Anti-Gouty Nephropathy Potential of Polysaccharides from Atractylodes chinensis
EP1200482A1 (en) Hematopoietic arabinogalactan composition
Musthoza et al. In vitro analysis of anticancer potential of green okra (Abelmoschus esculentus L.) polysaccharide extracts in HeLa cervical cancer cell line
CN100554326C (zh) 一种黄精免疫多糖、其组合物和它的用途
Hao et al. Echinops Spp. polysaccharide B ameliorates metabolic abnormalities in a rat model of type 2 diabetes mellitus.
Yang et al. Structure characterization, immunological activity, and mechanism of a polysaccharide from the rhizome of Menispermum dauricum DC
KR102258590B1 (ko) 다시마 및 한방 약재 추출물을 포함하는 호흡기 질환 개선용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180622

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190913